Article
Integrated genomic analysis of survival outliers in glioblastoma
28 Oct 2016
Abstract excerpt
Background: To elucidate molecular features associated with disproportionate survival of glioblastoma (GB) patients, we conducted deep genomic comparative analysis of a cohort of patients receiving standard therapy (surgery plus concurrent radiation and temozolomide); "GB outliers" were identified: long-term survivor of 33 months (LTS; n = 8) versus short-term survivor of 7 months (STS; n = 10). Methods: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
